SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 2,167.83 |
| Enterprise Value ($M) | 2,878.97 |
| Book Value ($M) | -475.93 |
| Book Value / Share | -2.27 |
| Price / Book | -4.55 |
| NCAV ($M) | -522.00 |
| NCAV / Share | -2.49 |
| Price / NCAV | -4.15 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.15 |
| Return on Assets (ROA) | -0.11 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.88 |
| Current Ratio | 2.93 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 409.98 |
| Assets | 480.05 |
| Liabilities | 931.97 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 450.71 |
| Operating Income | -1.28 |
| Net Income | -88.88 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -52.02 |
| Cash from Investing | 52.59 |
| Cash from Financing | -5.76 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock, Inc. | 8.40 | -16.91 | |
| 13G/A | Vanguard Group Inc | 9.81 | 0.00 | |
| 13G/A | State Street Corp | 4.30 | -30.74 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 650,300 | 4,653,957 | 13.97 | |
| 1,012,278 | 5,322,281 | 19.02 | |
| 1,091,621 | 6,615,312 | 16.50 | |
| 1,245,887 | 6,755,421 | 18.44 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AVIR – Atea Pharmaceuticals, Inc. | AVXL – Anavex Life Sciences Corp. |
| BBIO – BridgeBio Pharma, Inc. | BDTX – Black Diamond Therapeutics, Inc. |
| BEAM – Beam Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io